US 11185572
Mesenchymal stem cells for the treatment of CNS diseases
granted A61KA61K35/12A61K35/28
Quick answer
US patent 11185572 (Mesenchymal stem cells for the treatment of CNS diseases) held by BRAINSTORM CELL THERAPEUTICS LTD. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BRAINSTORM CELL THERAPEUTICS LTD.
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K35/12, A61K35/28, A61K38/185, A61P